REGN : Analysis & Opinions

  1. Regeneron/Sanofi's PCSK9 Drug Gets FDA Priority Review - Analyst ...

    January 27, 2015
    Regeneron (REGN) and Sanofi's (SNY) PCSK9 antibody, Praluent is under priority review in the U.S. for the treatment of patients ...
  2. Can Celgene (CELG) Beat Earnings on Strong Product Sales? - Analyst ...

    January 27, 2015
    Celgene Corporation is scheduled to report fourth-quarter 2014 results on Jan 29, before the opening bell.
  3. Will Alexion's (ALXN) Soliris Drive Q4 Earnings Beat? - Analyst ...

    January 27, 2015
    Alexion Pharmaceuticals, Inc. (ALXN) is scheduled to report its fourth-quarter 2014 results on Jan 29, before the opening ...
  4. Stock Market News for January 21, 2015 - Market News

    January 21, 2015
    Benchmarks ended Tuesday’s choppy trading session in the green led by gains from technology shares
  5. The Biggest Biotech Companies

    January 15, 2015
    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
  6. Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics ...

    January 14, 2015
    Preliminary fourth quarter results and expectations for 2015 were key highlights in the biotech sector.
  7. Aegerion Reveals Preliminary 2014 Results and 2015 Outlook - ...

    January 13, 2015
    Aegerion Pharmaceuticals, Inc. (AEGR) announced preliminary 2014 net product sales estimates and an outlook for 2015 besides ...
  8. Regeneron/Sanofi Seek PCSK9 Drug Praluent Approval in EU - Analyst ...

    January 12, 2015
    Regeneron and Sanofi announced that the Marketing Authorisation Application for Praluent has been accepted by the European ...
  9. Stock Market News for December 26, 2014 - Market News

    December 26, 2014
    Markets ended modestly higher on Wednesday’s abbreviated trading session banking on initial claims dropping to a seven-week ...
  10. Stock Market News for December 16, 2014 - Market News

    December 16, 2014
    Markets finished a choppy session in the negative territory on Monday as yet another slide in oil prices dented investor ...
  11. Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook

    March 25, 2014
    Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
  12. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  13. Market Wrap: Stocks End Flat, but Tesla Shares Sag After Hours

    November 5, 2013
    Stocks ended Tuesday basically flat, as investors started to focus on economic realities. But the market could see some ...
  14. Biotechnology: Some of the Strongest Stocks on Nearly Any Time ...

    September 18, 2013
    Biotechnology is an industry which as has lead the very strong healthcare sector on almost every time frame over the last ...
  15. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    September 14, 2013
    Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
  16. Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, ...

    June 26, 2013
    Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest ...
  17. Back to Neutral on Bayer - Analyst Blog

    December 26, 2012
    We are reverting to a Neutral recommendation on Bayer (BAYRY) as we believe that all the positive news that led to our previous ...
  18. Regeneron Pharmaceuticals Among Healthcare's Biggest Movers on ...

    November 30, 2012
    This morning's trading has marked a bad day for the market so far. The Nasdaq has decreased 0.4%; the S&P 500 has slipped ...
  19. Regeneron Pharmaceuticals and More Big Movers on the Nasdaq on ...

    November 16, 2012
    The market has been slipping so far today: the Nasdaq is trading down 1%; the S&P 500 is down 0.6%; and the Dow has slipped ...
  20. Fresenius Medical Care AG & Co and Other Big Movers In Healthcare ...

    November 1, 2012
    The Nasdaq has moved up 1.5%, the S&P 500 is trading up 1.1% and the Dow has risen 1.1%, marking a bad morning for the ...
  21. Healthcare Stocks, Including Gilead, Making Big Moves on October ...

    October 24, 2012
    So far today, the Nasdaq remains relatively unchanged, the S&P 500 has risen 0.1% and the Dow has climbed 0.3%. The healthcare ...
  22. Biotech Stocks With Bullish Trends From Short Sellers

    March 26, 2012
    One of the clearest sentiment indicators comes from short sellers. Changes in the number of shares shorted over time can ...
  23. 4 Overbought Stocks To Watch

    January 16, 2012
    Stocks with an RSI reading over 80
  24. Sanofi's Investment Prospects

    December 21, 2011
    Sanofi has emerged as an unheralded value in pharmaceuticals.
  25. XOMA Rearranges The Deck Chairs One More Time

    September 2, 2011
    XOMA changes management again, but should anybody care?
Trading Center